CVS Group PLC, a leading provider of integrated veterinary services in the UK, has issued a correction to its previous announcement regarding the exercise of options and confirms that on 4th January 2024, options over a total of 148,032 ordinary shares were exercised under the CVS Group 2020 SAYE Plan and 6,733 Ordinary Shares under the CVS Group Long Term Incentive Plan 2020. The issuance of shares in connection with the LTIP 14 exercise was fully satisfied by shares held by the CVS Group Employee Benefit Trust.
Robin Alfonso, the Chief Financial Officer, exercised options over 606 Ordinary Shares in the Company under the SAYE plan and an additional 6,733 Ordinary Shares under the LTIP 14 scheme. Following this, he sold 3,218 Ordinary Shares at the price of £16.17 each to meet the costs of exercise incurred as a PDMR option-holder, including personal taxation. After these transactions, Robin Alfonso holds a beneficial interest in 23,373 Ordinary Shares in the Company, representing approximately 0.033% of the total voting rights of the Company.
The Company has a total issued share capital of 71,685,694 Ordinary Shares, with no Ordinary Shares held in treasury. Therefore, the total number of voting rights in the Company will be 71,685,694. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
The notification also includes details of the person discharging managerial responsibilities and persons closely associated with them, as well as the contacts for further information.
This announcement provides a comprehensive update on the exercise of options, PDMR dealing, and total voting rights within CVS Group PLC, ensuring transparency and compliance with regulatory requirements.